SU2C-supported Research Yields New Insights Into Melanoma - Stand Up To Cancer


SU2C-supported Research Yields New Insights Into Melanoma

Scientists on the SU2C-Cancer Research Institute Immunology Dream Team and the SU2C-Melanoma Research Institute Melanoma Dream Team have separately reported findings that provide new insights into melanoma, the deadliest form of skin cancer. More than 75,000 cases of melanoma, and more than 10,000 deaths, are reported in the United States every year.  While the new immunotherapy drugs are highly effective against melanoma in some patients (like former President Jimmy Carter), they are not effective in all cases.  An SU2C-supported team at UCLA has reported findings on its research into the mechanisms of resistance which could lead to more effective immunotherapy.


Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.